4.6 Review

Fc receptors: genetic variation, function, and disease

期刊

IMMUNOLOGICAL REVIEWS
卷 268, 期 1, 页码 6-24

出版社

WILEY
DOI: 10.1111/imr.12341

关键词

Fc receptors; genetics; immunotherapy; antibodies

资金

  1. Experimental Cancer Medicine Centre (ECMC)
  2. Leukaemia and Lymphoma Research [11052, 12050]
  3. Wellcome Trust [087663]
  4. United Kingdom National Centre for the Replacement, Refinement and Reduction of Animals in Research CRACK IT Programme [NC/C011204/1]
  5. Kay Kendall Leukaemia Fund [KKL687]
  6. Uehara Memorial Foundation
  7. Roche
  8. GSK biopharm
  9. Pfizer, Inc.

向作者/读者索取更多资源

Fc receptors (FcRs) are key immune receptors responsible for the effective control of both humoral and innate immunity and are central to maintaining the balance between generating appropriate responses to infection and preventing autoimmunity. When this balance is lost, pathology results in increased susceptibility to cancer, autoimmunity, and infection. In contrast, optimal FcR engagement facilitates effective disease resolution and response to monoclonal antibody immunotherapy. The underlying genetics of the FcR gene family are a central component of this careful balance. Complex in humans and generated through ancestral duplication events, here we review the evolution of the gene family in mammals, the potential importance of copy number, and functionally relevant single nucleotide polymorphisms, as well as discussing current approaches and limitations when exploring genetic variation in this region.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据